Duearity AB Total Assets
Duearity AB total assets. Based on the latest financial reports, Duearity AB (DEAR) holds total assets worth Skr10.84 Million SEK (≈ $1.17 Million USD) as of June 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see DEAR company net worth for the company's overall valuation and market capitalisation.
Total Assets of Duearity AB (2020–2023)
Total assets of Duearity AB from 2020 to 2023. This chart illustrates how Duearity AB's total assets have evolved over time, based on quarterly financial data. See DEAR stock price for real-time trading data and today's change.
Duearity AB - Asset Composition Analysis
Duearity AB Total Assets Breakdown (December 2023)
Duearity AB total assets breakdown as of December 2023. Duearity AB's total assets of Skr10.84 Million consist of 84.3% current assets and 15.7% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 2.3% |
| Accounts Receivable | Skr7.11 Million | 47.0% |
| Inventory | Skr4.16 Million | 27.5% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr0.00 | 0.0% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2020–2023)
This chart illustrates how Duearity AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore DEAR working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Duearity AB's current assets represent 84.3% of total assets in 2023, a decrease from 100.0% in 2020.
- Cash Position: Cash and equivalents constituted 2.3% of total assets in 2023, down from 92.4% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 47.0% of total assets.
Duearity AB Competitors by Total Assets
Key competitors of Duearity AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Duearity AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.37 | 1.62 | 3.65 |
| Quick Ratio | 0.09 | 1.07 | 3.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr-12.42 Million | Skr4.85 Million | Skr4.03 Million |
Duearity AB - Advanced Valuation Insights
This section examines the relationship between Duearity AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.50 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 25.6% |
| Total Assets | Skr15.14 Million |
| Market Capitalization | $331.97K USD |
Valuation Analysis
Below Book Valuation: The market values Duearity AB's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Duearity AB's assets grew by 25.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Duearity AB (2020–2023)
The table below shows the annual total assets of Duearity AB from 2020 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | Skr15.14 Million ≈ $1.63 Million |
+25.62% |
| 2022-12-31 | Skr12.05 Million ≈ $1.30 Million |
-25.06% |
| 2021-12-31 | Skr16.09 Million ≈ $1.73 Million |
+267.42% |
| 2020-12-31 | Skr4.38 Million ≈ $471.14K |
-- |
About Duearity AB
Duearity AB (publ), a medical technology company, engages in the development and production of solutions for tinnitus. The company offers Tinearity G1, a medical device for people suffering from tinnitus that transmits white noise using bone conduction technology non-invasively to the inner ear in order to treat and relieve symptoms; and Tinearity-AI, which uses artificial intelligence to help pe… Read more